Medical Uses: Skyrizi is an interleukin-23 antagonist used for the treatment of:
- moderate-to-severe plaque psoriasis (Ps) in adults who are recipients for systemic therapy or phototherapy.
- active psoriatic arthritis (PsA) in adults.
- moderately-severely active Crohn’s disease (CD) in adults.
Plaque Psoriasis and Psoriatic Arthritis: The recommended dosage is 150 mg given by subcutaneous injection at Week 0, Week 4, and every 12 weeks thereafter.
Skyrizi injection may be administered alone or along with non-biologic disease-modifying antirheumatic drugs (DMARDs).
Crohn’s Disease: The recommended induction dosage is 600 mg given by intravenous infusion over at least one hour at Week 0, Week 4, and Week 8. The recommended maintenance dosage is 360 mg given by subcutaneous injection at Week 12, and every 8 weeks thereafter.
Obtain liver enzymes and bilirubin levels before initiating therapy with Risankizumab-rzaa injection. Avoid injecting into areas where the skin is tender, erythematous, bruised, indurated or affected by psoriasis. Administration of this medicine in the upper, outer arm may only be performed by a health specialist or caregiver.
In case any dose is missed, administer as soon as possible. Thereafter, resume dosing at the standard scheduled time.
What documents are required to import SKYRIZI to India?
SKYRIZI (Risankizumab-rzaa) Injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is SKYRIZI available in India?
SKYRIZI (Risankizumab-rzaa Injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability of skyrizi in India (Ahmedabad, Mumbai, Kolkata, Hyderabad, Chennai, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
SKYRIZI can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of SKYRIZI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at firstname.lastname@example.org for skyrizi injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the SKYRIZI (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Skyrizi®?
Risankizumab-rzaa is Generic Name for the trade name drug Skyrizi®.
What is the Manufacturer Name of Skyrizi®?
Skyrizi® is manufactured by AbbVie Inc.
Is Skyrizi® approved by the FDA?
Yes, Skyrizi® is approved by the FDA. Date of first/initial approval: April 23, 2019.
What is the dosage and form of Skyrizi® supplied?
Skyrizi® is supplied as Injection: 150 mg/mL in each single-dose prefilled pen, 150 mg/mL & 75 mg/0.83 mL in each single-dose prefilled syringe for subcutaneous use.
What are the most common side effects with Skyrizi®?
The most common side effects with Skyrizi® include: Plaque Psoriasis and Psoriatic Arthritis: tinea infections, upper respiratory infections, injection site reactions, headache, and fatigue.
Crohn’s Disease: upper respiratory infections, headache, and arthralgia (Induction), arthralgia, injection site reactions, abdominal pain, pyrexia, anemia, back pain, arthropathy, and urinary tract infection (Maintenance).
How much does Skyrizi® cost in India?
The skyrizi 150 mg injection cost in India is reasonable. To procure this interleukin-23 antagonist authentically, you can Call/WhatsApp +91-9310090915 or send mail to email@example.com.
What are the storage conditions of Skyrizi®?
Store in a refrigerator at 2-8°C (36-46° F). Neither freeze nor shake. Keep prefilled pens and syringes in the original cartons in order to protect from the light.
Is it safe to buy Skyrizi® online in India?
Yes, You can buy skyrizi injection online in India at the best price from Indian Pharma Network if Skyrizi® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Skyrizi®?
Click Here to download full Skyrizi prescribing information.